2-甲基-2-丙基(5-氰基-2-萘基)氨基甲酸酯 | 685902-47-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 中文名称: 2-甲基-2-丙基(5-氰基-2-萘基)氨基甲酸酯
• 英文名称: (5-cyanonaphthalen-2-yl)carbamic acid tert-butyl ester
• 英文别名: tert-Butyl (5-cyanonaphthalen-2-yl)carbamate；tert-butyl N-(5-cyanonaphthalen-2-yl)carbamate
• CAS: 685902-47-0
• 化学式: C₁₆H₁₆N₂O₂
• 分子量: 268.315
• InChiKey: PVTKPUIVOZEIPL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.5
• 重原子数：
  20
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  62.1
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  2-甲基-2-丙基(5-氰基-2-萘基)氨基甲酸酯 在 吡啶 、 sodium tetrahydroborate 作用下， 以 乙醇 、 溶剂黄146 为溶剂， 反应 4.0h， 生成 [5-(羟基甲基)-2-萘基]-氨基甲酸叔丁酯
  参考文献：
  名称：

  Design and Syntheses of 1,6-Naphthalene Derivatives as Selective HCMV Protease Inhibitors

  摘要：

  Through high throughput screening of various libraries, substituted styryl naphthalene 6 was identified as an HCMV protease inhibitor. Optimization of various regions of the lead molecule using parallel synthesis resulted in 1,6-substituted naphthalenes 19d-i. These compounds displayed good potency and were selective over elastase, trypsin, and chymotrypsin. The optimization approach on lead compound 6 in three different regions of the molecule using parallel solution-phase synthesis and the corresponding SAR are discussed in detail.

  DOI：

  10.1021/jm030540h
• 作为产物：
  描述：

  5-溴-2-萘甲酸甲酯 在 吡啶 、 sodium hydroxide 、 叠氮磷酸二苯酯 、 三乙胺 作用下， 以 甲醇 、 N,N-二甲基甲酰胺 为溶剂， 反应 78.0h， 生成 2-甲基-2-丙基(5-氰基-2-萘基)氨基甲酸酯
  参考文献：
  名称：

  Design and Syntheses of 1,6-Naphthalene Derivatives as Selective HCMV Protease Inhibitors

  摘要：

  Through high throughput screening of various libraries, substituted styryl naphthalene 6 was identified as an HCMV protease inhibitor. Optimization of various regions of the lead molecule using parallel synthesis resulted in 1,6-substituted naphthalenes 19d-i. These compounds displayed good potency and were selective over elastase, trypsin, and chymotrypsin. The optimization approach on lead compound 6 in three different regions of the molecule using parallel solution-phase synthesis and the corresponding SAR are discussed in detail.

  DOI：

  10.1021/jm030540h

文献信息

• Hypoxia-Activated Prodrugs: Substituent Effects on the Properties of Nitro <i>seco</i>-1,2,9,9a-Tetrahydrocyclopropa[<i>c</i>]benz[<i>e</i>]indol-4-one (nitroCBI) Prodrugs of DNA Minor Groove Alkylating Agents
  作者：Moana Tercel、Graham J. Atwell、Shangjin Yang、Ralph J. Stevenson、K. Jane Botting、Maruta Boyd、Eileen Smith、Robert F. Anderson、William A. Denny、William R. Wilson、Frederik B. Pruijn

  DOI：10.1021/jm901202b

  日期：2009.11.26

  Nitrochloromethylbenzindolines (nitroCBIs) are a new class of hypoxia-activated prodrugs for antitumor therapy. The recently reported prototypes undergo hypoxia-selective metabolism to form potent DNA minor groove alkylating agents and are selectively toxic to some but not all hypoxic tumor cell lines. Here we report a series of 31 analogues that bear an extra electron-withdrawing substituent that serves to raise the one-electron reduction potential of the nitroCBI. We identify a subset of compounds, those with a basic side chain and sulfonamide or carboxamide substituent, that have consistently high hypoxic selectivity. The best of these, with a 7-sulfonamide substituent, displays hypoxic cytotoxicity ratios of 275 and 330 in Skov3 and HT29 human tumor cell lines, respectively. This compound (28) is efficiently and selectively metabolized to the corresponding aminoCBI, is selectively cytotoxic tinder hypoxia in all 11 cell lines examined, and demonstrates activity against hypoxic tumor cells in a human tumor xenograft in vivo.
• US7223786B2
  申请人：——

  公开号：US7223786B2

  公开（公告）日：2007-05-29
• Design and Syntheses of 1,6-Naphthalene Derivatives as Selective HCMV Protease Inhibitors
  作者：Ariamala Gopalsamy、Kitae Lim、John W. Ellingboe、Boris Mitsner、Antonia Nikitenko、Janis Upeslacis、Tarek S. Mansour、Matthew W. Olson、Geraldine A. Bebernitz、Diane Grinberg、Boris Feld、Franklin J. Moy、John O'Connell

  DOI：10.1021/jm030540h

  日期：2004.4.1

  Through high throughput screening of various libraries, substituted styryl naphthalene 6 was identified as an HCMV protease inhibitor. Optimization of various regions of the lead molecule using parallel synthesis resulted in 1,6-substituted naphthalenes 19d-i. These compounds displayed good potency and were selective over elastase, trypsin, and chymotrypsin. The optimization approach on lead compound 6 in three different regions of the molecule using parallel solution-phase synthesis and the corresponding SAR are discussed in detail.